{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:24:20Z","timestamp":1793319860536,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"am","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.neurol.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T07:39:40Z","timestamp":1671694780000},"page":"10-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Strategy for genetic analysis in hereditary neuropathy"],"prefix":"10.1016","volume":"179","author":[{"given":"M.","family":"Masingue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fern\u00e1ndez-Eulate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Labeyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Leonard-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-M.","family":"Dhaenens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2022.11.007_bib0840","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.mcna.2018.10.006","article-title":"Peripheral Neuropathy","volume":"103","author":"Barrell","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.neurol.2022.11.007_bib0845","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","article-title":"Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus","volume":"270","author":"Kato-Motozaki","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.007_bib0850","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ajmg.1320600606","article-title":"Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in P\u00f3voa do Varzim and Vila do Conde (north of Portugal)","volume":"60","author":"Sousa","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib0855","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2016-313960","article-title":"Peripheral neuropathy in complex inherited diseases: an approach to diagnosis","volume":"88","author":"Rossor","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib0860","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1212\/WNL.0000000000000691","article-title":"Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy","volume":"83","author":"Liu","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib0865","doi-asserted-by":"crossref","DOI":"10.1002\/humu.24445","article-title":"Expanding the phenotypic variability of MORC2 gene mutations: from Charcot-Marie-Tooth disease to late-onset pure motor neuropathy","author":"Jacquier","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2022.11.007_bib0870","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajhg.2020.06.013","article-title":"De novo variants in the ATPase module of MORC2 cause a neurodevelopmental disorder with growth retardation and variable craniofacial dysmorphism","volume":"107","author":"Guillen Sacoto","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib0875","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00415-011-5900-9","article-title":"A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patient","volume":"258","author":"Dubourg","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0880","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/brain\/awaa418","article-title":"Bi-allelic truncating mutations in VWA1 cause neuromyopathy","volume":"144","author":"Deschauer","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib0885","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.25804","article-title":"MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy","volume":"88","author":"Dahlqvist","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0890","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nmd.2021.11.003","article-title":"Muscle \u201cislands\u201d: an MRI signature distinguishing neurogenic from myopathic causes of early onset distal weakness","volume":"32","author":"Astrea","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2022.11.007_bib0895","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1007\/s00330-021-07931-9","article-title":"MR imaging of inherited myopathies: a review and proposal of imaging algorithms","volume":"31","author":"Aivazoglou","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0900","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nmd.2019.08.011","article-title":"MYO-MRI diagnostic protocols in genetic myopathies","volume":"29","author":"Warman Chardon","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2022.11.007_bib0905","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0035-1545076","article-title":"Hereditary and acquired polyneuropathy conditions of the peripheral nerves: clinical considerations and MR neurography imaging","volume":"19","author":"Trivedi","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0910","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.2147\/IJGM.S295851","article-title":"Review article \u201cSpotlight on Ultrasonography in the Diagnosis of Peripheral Nerve Disease: The Evidence to Date.\u201d","volume":"14","author":"Hannaford","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib0915","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1212\/01.WNL.0000059262.34846.8A","article-title":"Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins?","volume":"60","author":"Pareyson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib0920","series-title":"Kearns Sayre syndrome","author":"Shemesh","year":"2022"},{"key":"10.1016\/j.neurol.2022.11.007_bib0925","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ng1097-190","article-title":"Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene","volume":"17","author":"Jansen","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib0930","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1111\/ene.15001","article-title":"Charcot-Marie-Tooth disease due to MORC2 mutations in Spain","volume":"28","author":"Sivera","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0935","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awr148","article-title":"Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P- phosphatase FIG4","volume":"134","author":"Nicholson","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib0940","series-title":"GeneReviews\u00ae","article-title":"Long-chain hydroxyacyl-CoA dehydrogenase deficiency\/trifunctional protein deficiency","author":"Prasun","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib0945","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnen\/nlx111","article-title":"Nerve biopsy is still useful in some inherited neuropathies","volume":"77","author":"Duchesne","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0950","doi-asserted-by":"crossref","first-page":"e021632","DOI":"10.1136\/bmjopen-2018-021632","article-title":"Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation","volume":"8","author":"Bacquet","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.neurol.2022.11.007_bib0955","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/genes13020318","article-title":"A National French Consensus on Gene List for the Diagnosis of Charcot-Marie-Tooth disease and related disorders using next-generation sequencing","volume":"13","author":"Benquey","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.neurol.2022.11.007_bib0960","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acn3.50797","article-title":"Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan","volume":"6","author":"Hsu","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib0965","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-9-38","article-title":"PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies","volume":"9","author":"van Paassen","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib0970","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12031-020-01488-w","article-title":"PMP22 gene-associated neuropathies: phenotypic spectrum in a cohort from India","volume":"70","author":"Nagappa","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurol.2022.11.007_bib0975","series-title":"GeneReviews\u00ae","article-title":"Hereditary neuropathy with liability to pressure palsies","author":"Chrestian","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib0980","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.84.14_supplement.P3.182","article-title":"Hereditary neuropathy with liability to pressure palsies (HNPP) and leprosy neuropathy: a comparative nerve conduction study (P3.182)","volume":"84","author":"Oliveira","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib0985","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/mus.25666","article-title":"Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: neurophysiological data and proposed electrodiagnostic criteria","volume":"57","author":"Robert-Varvat","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2022.11.007_bib0990","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jns.12452","article-title":"Loss of function MPZ mutation causes milder CMT1B neuropathy","volume":"26","author":"Howard","year":"2021","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib0995","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2010.12.010","article-title":"Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a myelin protein zero p.Ile112Thr mutation","volume":"21","author":"Murphy","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2022.11.007_bib1000","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/brain\/awv241","article-title":"Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene","volume":"138","author":"Sanmaneechai","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1005","series-title":"GeneReviews\u00ae","article-title":"SH3TC2-related hereditary motor and sensory neuropathy","author":"Azzedine","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib1010","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.wnl.0000230225.19797.93","article-title":"Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations","volume":"67","author":"Azzedine","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1529-8027.2012.00382.x","article-title":"Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C","volume":"17","author":"Yger","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib1020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jns5.12026","article-title":"Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes","volume":"18","author":"Tazir","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib1025","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/ene.14950","article-title":"Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: an international multicentric retrospective study","volume":"28","author":"Hauw","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1030","series-title":"GeneReviews\u00ae","article-title":"GJB1 disorders: Charcot-Marie-Tooth Neuropathy (CMT1X) and central nervous system phenotypes","author":"Abrams","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib1035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00441-014-2014-6","article-title":"GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems","volume":"360","author":"Abrams","year":"2015","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurol.2022.11.007_bib1040","doi-asserted-by":"crossref","first-page":"e200019","DOI":"10.1212\/NXG.0000000000200019","article-title":"Alanyl-tRNA synthetase 1 gene variants in hereditary neuropathy: genotype and phenotype overview","volume":"8","author":"Setlere","year":"2022","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.033","article-title":"MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives","volume":"356","author":"Stuppia","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.007_bib1050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","article-title":"Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes","volume":"52","author":"Cortese","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1055","doi-asserted-by":"crossref","first-page":"e3163","DOI":"10.1212\/WNL.0000000000011132","article-title":"The genetic landscape of axonal neuropathies in the middle-aged and elderly: focus on MME","volume":"95","author":"Senderek","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1060","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1212\/WNL.0b013e3181a609e3","article-title":"SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy","volume":"72","author":"Hannibal","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jon.12210","article-title":"Neuroimaging in sensory neuronopathy","volume":"25","author":"Casseb","year":"2015","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.neurol.2022.11.007_bib1070","doi-asserted-by":"crossref","first-page":"E1028","DOI":"10.3390\/cells9041028","article-title":"Charcot-Marie-Tooth type 2B: a new phenotype associated with a novel RAB7A mutation and inhibited EGFR degradation","volume":"9","author":"Saveri","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neurol.2022.11.007_bib1075","series-title":"GeneReviews\u00ae","article-title":"SPTLC1-related hereditary sensory neuropathy","author":"Nicholson","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib1080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12017-015-8379-1","article-title":"The variant p.(Arg183Trp) in SPTLC2 causes late-onset hereditary sensory neuropathy","volume":"18","author":"Suriyanarayanan","year":"2016","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib1085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ng.830","article-title":"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss","volume":"43","author":"Klein","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajhg.2010.12.003","article-title":"Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I","volume":"88","author":"Guelly","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1095","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/jnnp-2020-323719","article-title":"Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic","volume":"91","author":"Cortese","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib1100","series-title":"GeneReviews\u00ae","article-title":"RFC1 CANVAS\/spectrum disorder","author":"Cortese","year":"1993"},{"key":"10.1016\/j.neurol.2022.11.007_bib1105","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1212\/WNL.0000000000011528","article-title":"Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 Disease","volume":"96","author":"Trasch\u00fctz","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.26382","article-title":"Delayed-onset Friedreich's ataxia revisited","volume":"31","author":"Lecocq","year":"2016","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jnc.12217","article-title":"Cardiomyopathy of Friedreich ataxia","volume":"126","author":"Weidemann","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2022.11.007_bib1120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12883-018-1201-6","article-title":"A novel nonsense mutation in WNK1\/HSN2 associated with sensory neuropathy and limb destruction in four siblings of a large Iranian pedigree","volume":"18","author":"Rahmani","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1125","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ajmg.a.62727","article-title":"Novel RETREG1 (FAM134B) founder allele is linked to HSAN2B and renal disease in a Turkish family","volume":"188","author":"Ta\u015fdelen","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.neurol.2022.11.007_bib1130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajhg.2011.06.013","article-title":"KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2","volume":"89","author":"Rivi\u00e8re","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jmg.2005.039230","article-title":"Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia","volume":"43","author":"Bouhouche","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jbspin.2017.11.002","article-title":"Small fiber neuropathy: diagnosis, causes, and treatment","volume":"85","author":"S\u00e8ne","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.neurol.2022.11.007_bib1145","doi-asserted-by":"crossref","first-page":"E989","DOI":"10.3390\/brainsci10120989","article-title":"Contribution of skin biopsy in peripheral neuropathies","volume":"10","author":"Nolano","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.neurol.2022.11.007_bib1150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neurol.2022.11.007_bib1155","doi-asserted-by":"crossref","first-page":"E8080","DOI":"10.3390\/ijms21218080","article-title":"Biomarkers in Anderson-Fabry disease","volume":"21","author":"Simonetta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2022.11.007_bib1160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","article-title":"Painful and painless channelopathies","volume":"13","author":"Bennett","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1165","first-page":"370","article-title":"Charcot-Marie-Tooth disease and related peripheral neuropathies","volume":"2","author":"De Jonghe","year":"1997","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib1170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbadis.2006.08.005","article-title":"Molecular biology of distal muscular dystrophies\u00a0\u2013\u00a0sarcomeric proteins on top","volume":"1772","author":"Udd","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurol.2022.11.007_bib1175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/humu.23189","article-title":"Axonal neuropathies due to mutations in small heat shock proteins: clinical, genetic, and functional insights into novel mutations","volume":"38","author":"Echaniz-Laguna","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.neurol.2022.11.007_bib1180","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/ene.14272","article-title":"Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study","volume":"27","author":"Fern\u00e1ndez-Eulate","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1185","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1212\/01.wnl.0000218304.02715.04","article-title":"The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V","volume":"66","author":"Dubourg","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1190","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.0000000000001269","article-title":"Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy","volume":"84","author":"Scoto","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1195","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1212\/WNL.0000000000000450","article-title":"Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy","volume":"82","author":"Echaniz-Laguna","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1200","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/brain\/awu356","article-title":"Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2","volume":"138","author":"Rossor","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1210","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/brain\/awaa311","article-title":"The expanding genetic landscape of hereditary motor neuropathies","volume":"143","author":"Beijer","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1215","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ene.14700","article-title":"Distal hereditary motor neuropathies: mutation spectrum and genotype-phenotype correlation","volume":"28","author":"Frasquet","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.neurol.2022.11.007_bib1230","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the global prevalence of transthyretin familial amyloid polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2022.11.007_bib1240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-019-1000-1","article-title":"Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series","volume":"14","author":"Waddington-Cruz","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","article-title":"Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease","volume":"15","author":"Adams","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1250","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurol.2021.02.392","article-title":"Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France","volume":"177","author":"Davion","year":"2021","journal-title":"Rev Neurol (Paris)"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2012.685665","article-title":"Regional difference and similarity of familial amyloidosis with polyneuropathy in France","volume":"19","author":"Adams","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.neurol.2022.11.007_bib1260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1265","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000154146","article-title":"Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence","volume":"43","author":"Sousa","year":"1993","journal-title":"Hum Hered"},{"key":"10.1016\/j.neurol.2022.11.007_bib1270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000490553","article-title":"Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal: a nationwide study","volume":"51","author":"In\u00eas","year":"2018","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.20644","article-title":"Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal","volume":"35","author":"Concei\u00e7\u00e3o","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2022.11.007_bib1280","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp-2013-305383","article-title":"Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M","volume":"85","author":"Lemos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib1285","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1136\/jmg.40.11.e120","article-title":"Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families","volume":"40","author":"Plant\u00e9-Bordeneuve","year":"2003","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13506129.2003.12088566","article-title":"Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan","volume":"10","author":"Sobue","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.neurol.2022.11.007_bib1295","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.24519","article-title":"Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France","volume":"78","author":"Mariani","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1300","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1212\/WNL.0000000000005777","article-title":"Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy","volume":"91","author":"Lozeron","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1305","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp-2016-315262","article-title":"Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy","volume":"88","author":"Cortese","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13506129.2012.665400","article-title":"Genotype--phenotype correlation in FAP","volume":"19","author":"Zeldenrust","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.neurol.2022.11.007_bib1315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"Maia","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib1320","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.neurol.2022.11.007_bib1325","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13506129.2017.1301419","article-title":"Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial","volume":"24","author":"Keohane","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.neurol.2022.11.007_bib1335","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2022.11.007_bib1340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib1345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1350","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/WCO.0000000000000290","article-title":"Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis","volume":"29","author":"Obici","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1355","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/B978-0-444-52902-2.00039-4","article-title":"Hereditary gelsolin amyloidosis","volume":"115","author":"Kiuru-Enari","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-020-1300-5","article-title":"Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study","volume":"15","author":"Schmidt","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1365","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/1873-3468.12468","article-title":"Apolipoprotein A-I: the dual face of a protein","volume":"590","author":"Arciello","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neurol.2022.11.007_bib1370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12881-019-0755-5","article-title":"A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options","volume":"20","author":"Moutafi","year":"2019","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/nep.12108","article-title":"Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland","volume":"18","author":"Traynor","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.neurol.2022.11.007_bib1380","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/lt.21176","article-title":"Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: outcome of hepatorenal transplantation","volume":"13","author":"Testro","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.neurol.2022.11.007_bib1385","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp-2021-328045","article-title":"Diagnostic approach in adult-onset neurometabolic diseases","volume":"93","author":"Fern\u00e1ndez-Eulate","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib1390","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10545-007-0684-x","article-title":"Peripheral neuropathy and inborn errors of metabolism in adults","volume":"30","author":"Sedel","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1395","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurol.2010.07.041","article-title":"Peripheral neuropathies associated with hereditary cerebellar ataxias","volume":"167","author":"Anheim","year":"2011","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2022.11.007_bib1400","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.5551\/jat.RV17056","article-title":"Current diagnosis and management of abetalipoproteinemia","volume":"28","author":"Takahashi","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.neurol.2022.11.007_bib1405","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1410","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1415","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13023-014-0207-4","article-title":"29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype","volume":"9","author":"Monin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1420","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10545-005-0533-8","article-title":"Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency","volume":"28","author":"Olpin","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1425","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/mds.28307","article-title":"Autosomal recessive cerebellar ataxias with elevated Alpha-Fetoprotein: uncommon diseases, common biomarker","volume":"35","author":"Renaud","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2022.11.007_bib1430","doi-asserted-by":"crossref","first-page":"140555","DOI":"10.1016\/j.bbapap.2020.140555","article-title":"Deficit of human ornithine aminotransferase in gyrate atrophy: molecular, cellular, and clinical aspects","volume":"1869","author":"Montioli","year":"2021","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.neurol.2022.11.007_bib1435","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/ajmg.a.62245","article-title":"Adult diagnosis of congenital serine biosynthesis defect: a treatable cause of progressive neuropathy","volume":"185","author":"Debs","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.neurol.2022.11.007_bib1440","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaneurol.2017.4373","article-title":"Clinical, biomarker, and molecular delineations and genotype-phenotype correlations of ataxia with oculomotor Apraxia type 1","volume":"75","author":"Renaud","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1445","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/brain\/awp211","article-title":"Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients","volume":"132","author":"Anheim","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12311-015-0684-6","article-title":"Peripheral neuropathy in spinocerebellar Ataxia type 1, 2, 3, and 6","volume":"15","author":"Linnemann","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.neurol.2022.11.007_bib1455","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jmedgenet-2020-107007","article-title":"Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders","volume":"58","author":"Nicita","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1460","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neurol.2020.07.001","article-title":"Clinical and genetic update of hereditary spastic paraparesis","volume":"177","author":"Lallemant-Dudek","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2022.11.007_bib1465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/brain\/awv320","article-title":"ALS5\/SPG11\/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease","volume":"139","author":"Montecchiani","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1470","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00415-011-6340-2","article-title":"Clinical and electrophysiological characteristics of neuropathy associated with Tangier disease","volume":"259","author":"Zyss","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1475","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns.12265","article-title":"Peripheral neuropathy in Tangier disease: a literature review and assessment","volume":"23","author":"Mercan","year":"2018","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib1480","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00415-016-8167-3","article-title":"Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia","volume":"263","author":"Renaud","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.410350119","article-title":"Human beta-mannosidase deficiency associated with peripheral neuropathy","volume":"35","author":"Levade","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1490","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","article-title":"X-linked adrenoleukodystrophy: pathogenesis and treatment","volume":"14","author":"Engelen","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurol.2022.11.007_bib1495","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10545-018-0162-7","article-title":"Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes","volume":"41","author":"Amador","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1500","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-012-9560-4","article-title":"Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review","volume":"36","author":"Debs","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1505","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13023-019-1220-4","article-title":"Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective","volume":"14","author":"Beerepoot","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1510","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpeds.2006.06.034","article-title":"Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease","volume":"149","author":"Wasserstein","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.neurol.2022.11.007_bib1515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mus.20878","article-title":"Neurophysiological study in a Spanish family with recessive spastic ataxia of Charlevoix-Saguenay","volume":"37","author":"Garc\u00eda","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2022.11.007_bib1520","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1525","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.27232","article-title":"Porphyric neuropathy","volume":"64","author":"Gandhi Mehta","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2022.11.007_bib1530","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00431-006-0104-5","article-title":"Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency","volume":"165","author":"Debray","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.neurol.2022.11.007_bib1535","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/acn3.51160","article-title":"Severe neurological crisis in adult patients with Tyrosinemia type 1","volume":"7","author":"Dawson","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1540","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/17531934211061980","article-title":"Carpal tunnel syndrome and finger deformities in children with mucopolysaccharidoses and mucolipidoses: a retrospective review of 52 patients","volume":"47","author":"Thirache","year":"2022","journal-title":"J Hand Surg Eur Vol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1545","article-title":"Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies","author":"Carreau","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.11.007_bib1550","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.25689","article-title":"Natural history of adult patients with GM2 gangliosidosis","volume":"87","author":"Masingue","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1555","first-page":"100696","article-title":"Biotinidase deficiency is a rare, potentially treatable cause of peripheral neuropathy with or without optic neuropathy in adults","volume":"26","author":"Kellom","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.neurol.2022.11.007_bib1560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neurol.2017.03.034","article-title":"Hereditary spastic paraplegia: more than an upper motor neuron disease","volume":"173","author":"Parodi","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2022.11.007_bib1565","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2016.03.001","article-title":"Late-onset spastic paraplegia type 10 (SPG10) family presenting with bulbar symptoms and fasciculations mimicking amyotrophic lateral sclerosis","volume":"364","author":"Kaji","year":"2016","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2022.11.007_bib1570","first-page":"62","article-title":"Peripheral neuropathy associated with mitochondrial myopathy","volume":"24","author":"Yiannikas","year":"1988","journal-title":"Aust Paediatr J"},{"key":"10.1016\/j.neurol.2022.11.007_bib1575","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneur.63.5.746","article-title":"Nerve conduction abnormalities in patients with MELAS and the A3243G mutation","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1580","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00415-003-0981-8","article-title":"Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA","volume":"250","author":"K\u00e4rpp\u00e4","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1585","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1529-8027.2002.02027.x","article-title":"Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature","volume":"7","author":"Bouillot","year":"2002","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.neurol.2022.11.007_bib1590","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1750-3639.1993.tb00742.x","article-title":"Neuropathy associated with mitochondrial disorders","volume":"3","author":"Schr\u00f6der","year":"1993","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2011.02.012","article-title":"Inherited mitochondrial neuropathies","volume":"304","author":"Finsterer","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.11.007_bib1600","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000117420","article-title":"Peripheral neuropathy in mitochondrial encephalomyopathies","volume":"37","author":"Chu","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1605","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mito.2016.07.014","article-title":"Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease","volume":"30","author":"Menezes","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurol.2022.11.007_bib1610","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.49.1.239","article-title":"Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease","volume":"49","author":"Fadic","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1615","first-page":"428","article-title":"A new mitochondrial disease associated with mitochondrial DNA heteroplasmy","volume":"46","author":"Holt","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2022.11.007_bib1620","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JND-200513","article-title":"Ganglionopathies associated with MERRF syndrome: an original report","volume":"7","author":"Michaud","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.neurol.2022.11.007_bib1625","doi-asserted-by":"crossref","first-page":"728043","DOI":"10.3389\/fendo.2021.728043","article-title":"The mutations and clinical variability in maternally inherited diabetes and deafness: an analysis of 161 patients","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.neurol.2022.11.007_bib1630","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.WNL.0000031795.91814.D8","article-title":"Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children","volume":"59","author":"Wolf","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1635","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria: diagnostic applications in children","volume":"67","author":"Morava","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.11.007_bib1640","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/gim.2017.125","article-title":"Revisiting mitochondrial diagnostic criteria in the new era of genomics","volume":"20","author":"Witters","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib1645","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s42399-021-00970-9","article-title":"Idiopathic hypersomnia in a patient suffering from MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes): a new mitochondrial feature?","volume":"3","author":"Tard","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib1650","unstructured":"Neuropathies h\u00e9r\u00e9ditaires sensitivomotrice de Charcot-Marie-Tooth. Haute Autorit\u00e9 de Sant\u00e9 n.d. https:\/\/www.has-sante.fr\/jcms\/p_3168018\/fr\/neuropathies-hereditaires-sensitivomotrice-de-charcot-marie-tooth.(accessed October 31, 2022)."},{"key":"10.1016\/j.neurol.2022.11.007_bib1655","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/NMM:8:1-2:123","article-title":"Intermediate forms of Charcot-Marie-Tooth neuropathy: a review","volume":"8","author":"Nicholson","year":"2006","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neurol.2022.11.007_bib1660","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ene.13079","article-title":"Nerve conduction velocity in CMT1A: what else can we tell?","volume":"23","author":"Manganelli","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.11.007_bib1665","first-page":"awac280","article-title":"RFC1 non-sense and frameshift variants cause CANVAS: clues for an unsolved pathophysiology","author":"Benkirane","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.11.007_bib1670","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722008463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722008463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:45:54Z","timestamp":1758519954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378722008463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":167,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0035378722008463"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategy for genetic analysis in hereditary neuropathy","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}